Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (4574)	11/1/1999 11:12:00 PM
From: out_of_the_loop	Read Replies (2) \| Respond to of 10293

Yes, the announcer on CNN Headline news looked pretty disappointed both times I saw Zicam's name mentioned on that broadcast tonight. Congrats to the dude who got the borrow on the uptick in the aftermarket trading. LOL

To: Kevin Podsiadlik who wrote (4574)	11/1/1999 11:33:00 PM
From: Mike M	Read Replies (1) \| Respond to of 10293

...and winding up publishing in any lesser journal (read: anything else, except maybe JAMA), must be a letdown to anyone who's been paying attention. That is your spin and you are sticking with it.... Do you think the typical mom really cares which journal published the findings? My guess is that the impact to the sales of Zicam between these two prestigious journals is negligible. I'll let the story play out. the only import of any journal was to publish a peer review in order to convince the busy doctors and the skeptical patrons what others already knew. GUMM works! The company already knew that. So did thousands of people without the first bit of advertisement. Now millions will. Kevin, you are trying awfully hard to make this positive a negative. It doesn't wash.